Harrow, Inc.
HROW
#5536
Rank
A$2.05 B
Marketcap
A$55.06
Share price
-8.19%
Change (1 day)
-0.06%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): A$19.37 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are A$0.26 Billion. In 2025 the company made an earning of A$32.66 Million, an increase over its 2024 earnings that were of A$7.82 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$19.37 M-40.7%
2025 A$32.66 M317.34%
2024 A$7.82 M-329.09%
2023 -A$3.42 Million-224.34%
2022 A$2.74 M3.01%
2021 A$2.66 M149.06%
2020 A$1.07 M434.29%
2019 A$0.2 M-102.68%
2018 -A$7.48 Million-57.11%
2017 -A$17.42 Million-21.93%
2016 -A$22.31 Million5.11%
2015 -A$21.23 Million46.16%
2014 -A$14.53 Million32.68%
2013 -A$10.95 Million42.63%
2012 -A$7.68 Million
2010 -A$3.55 Million-45.76%
2009 -A$6.54 Million21.83%
2008 -A$5.37 Million-491.97%
2007 A$1.36 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.33 Billion-2,013.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$26 Million-251.76%๐Ÿ‡บ๐Ÿ‡ธ USA